Abstract
Routine mixing studies are frequently used to evaluate patients presenting with prolonged partial thromboplastin times (PTT) and/or prothrombin times (PT). Unfortunately, mixing studies have a number of inherent limitations including lack of standardization in terms of what defines normal pooled plasma (NPP), the processing of a patient's plasma for platelet removal (platelet poor plasma versus platelet-free plasma), performance of appropriate controls, conducting an incubation step to evaluate for a time and temperature dependent inhibitor, and finally interpretation of test results. Moreover, misinterpretation of study results can lead to a delayed or incorrect diagnosis or worse, inappropriate treatment. Within this manuscript, we present four cases illustrating the shortcomings associated with inappropriate utilization and interpretation of routine mixing studies; and present practical steps for managing abnormal PT or PTT results.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 39-42 |
| Number of pages | 4 |
| Journal | Transfusion and Apheresis Science |
| Volume | 58 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 2019 |
Keywords
- Circulating coagulation inhibitor
- Lupus anticoagulant
- Mixing study
- Partial thromboplastin time
- Prothrombin time
ASJC Scopus subject areas
- Hematology
Fingerprint
Dive into the research topics of 'Prolonged partial thromboplastin time: To mix or not to mix – is that the question?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS